Peak Pharma Stock Price (OTCMKTS:PKPH)

Add to My Stocks
$0.11 $0.01 (10%) PKPH stock closing price Sep 19, 2018 (Closing)
Prev Close* : $0.1
Market Cap:
$8.03M
Day Low: $0.1
52 Week Low: $0.03
Open: $0.11
Volume: -
Day High: $0.13
52 Week High: $0.39
Dividend:
0.00

Latest Stock Market News

Latest Articles

Peak Pharma News - From Partners

PKPH Stockcharts

View PKPH PE ratio, PS ratio stocks charts and compare with peers.
PKPH Chart
Note: Compare Peak Pharma stock price history with the index and industry peers.

Peak Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Peak Pharma Returns

ROE
(return on equity)

Peak Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

PKPH Industry Peers

Company Price Change (%)
Protalex (PRTX)0.20.04 (25%)
Preveceutcl Med (PRVCF)0.060.01 (20%)
Targeted Medical (TRGM)0.010 (0%)
Myos Rens (MYOS)1.250.08 (6.02%)
Gelstat (GSAC)00 (0%)
Myos Rens (MYOS)1.250.08 (6.02%)
Conversion Labs (CVLB)0.240 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Peak Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-0.05M1.16M-2.3M-3.75M-0.01M
Total Operating Expense0-1.1M2.32M2.67M0
View Peak Pharma income statement
balance sheet20172016201520142013
Total Assets-----
Total Liabilities-----
Shareholders Equity-0.19M-0.14M-0.01M--0.03M
View Peak Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--0.08M---
Net Cash from (used by) Operating Activities-0.01M-0.2M-0.24M-0.93M-0.01M
Increase (Decrease) in Prop Plant And Equipment-----
View Peak Pharma cash flow statement

Peak Pharma Stock Message Board

As of last trading day, Peak Pharma stock price was $0.11. Stock price or share price can be used to find the total market value of a company. Peak Pharma market cap stands at $8.03M as of Sep 19, 2018. A value investor must look at the fundamentals of a stock, and perform Peak Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Peak Pharma stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy PKPH stock than sell it, then Peak Pharma stock price goes up. Conversely, if more investors wanted to sell PKPH stock than buy it, there would be greater supply than demand, and the stock price would fall. 111,711 shares were traded with a closing stock price of $0.11 as of Sep 19, 2018, as can be seen from Peak Pharma stock quote. One can view Peak Pharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Peak Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of PKPH, view Peak Pharma stock price history.